Genentech Slaps Down Biosimilar Imports: Patents vs. Patients?
Published Date: 3/4/2026
Notice
Summary
The U.S. International Trade Commission got a complaint from Genentech about certain pertuzumab biosimilars being imported and sold in the U.S. They want to stop these products because of patent issues. The Commission is asking the public to share their thoughts on how this might affect everyone, with decisions and possible actions happening soon, including a 60-day review period.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 1 costs, 1 mixed.
Genentech Seeks Import Ban and Orders
Genentech filed a complaint on February 27, 2026 alleging that certain pertuzumab biosimilars are unlawfully imported and sold in the U.S. The company asks the Commission for a limited exclusion order, cease and desist orders, and for a bond to be imposed on the allegedly infringing articles during the 60-day Presidential review period under 19 U.S.C. 1337(j).
Public Comment Window Is Short and Electronic
The Commission invites public comments on public interest issues and requires written submissions to be filed no later than close of business eight calendar days after this notice's publication; complainant may reply within three calendar days. All filings must be made electronically through the Commission's Electronic Document Information System (EDIS), submissions are limited to five (5) pages, and no paper filings will be accepted until further notice (Docket No. 3890).
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22911, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Honeywell Aerospace about some electronic control units that might be breaking import rules. Companies like Lucid and Rivian are involved, and the Commission wants your thoughts on how this affects the public. This could lead to import bans or sales stops soon, so keep an eye out if you’re connected to these products or companies.
2026-22904, Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint from Netlist, Inc. about certain memory devices like DRAM and NAND flash being imported and sold in the U.S. The complaint targets big tech companies like Kingston and Lenovo, and the Commission wants your thoughts on how this might affect the public. This could lead to changes in what memory products are allowed, so keep an eye out for updates!
2026-22923, Prestressed Concrete Steel Wire Strand From China; Determinations
The U.S. International Trade Commission decided to keep special taxes on prestressed concrete steel wire strand imported from China. This means U.S. companies making this steel are protected from unfairly cheap imports that could hurt their business. The decision was made in November 2026 and signals ongoing support for American steel makers.
2026-22768, Certain Glow Fish Tape Systems, Safety Helmet Systems, and Components Thereof; Notice of a Final Determination Finding a Violation of Section 337; Issuance of a Limited Exclusion Order and Cease and Desist Order; Termination of Investigation
The U.S. International Trade Commission found Milwaukee Electric Tool guilty of selling glow fish tape systems that break a patent owned by Klein Tools. Milwaukee must stop selling these products in the U.S. and face a limited ban on imports, with a 100% bond on any shipments during review. This means Milwaukee’s glow fish tape systems are officially off-limits, protecting Klein’s invention and shaking up the market.
2026-22730, Certain Foundry Coke; Notice of a Commission Determination Not To Review an Initial Determination Granting Complainants' Motion To Amend the Complaint and Notice of Investigation and To Terminate the Investigation as to Certain Claims
The U.S. International Trade Commission has agreed to let SunCoke add more patent claims against MTX Group in their foundry coke case and dropped all claims related to another patent against all parties. This means the investigation will focus on specific patent issues with MTX Group, speeding things up and sharpening the fight over imported foundry coke. If you’re involved, keep an eye on this as it could affect sales and imports soon.
2026-22595, Seamless Refined Copper Pipe and Tube From Vietnam; Scheduling of an Expedited Five-Year Review
The U.S. International Trade Commission is speeding up a review to decide if special taxes on seamless refined copper pipe and tube from Vietnam should stay or go. This affects U.S. businesses that make or sell these pipes and tubes, as well as importers from Vietnam. The decision, starting October 5, 2026, could impact prices and trade rules soon.
Previous / Next Documents
Previous: 2026-04235, Agency Information Collection Activities; Submission for OMB Review; Comment Request; Extension: Rule 204-2
The SEC is asking to keep the current rules that require investment advisers to keep important business records for at least five years. This affects all SEC-registered investment advisers, who spend a lot of time (about 185 hours each) on this paperwork. The SEC wants to extend this rule without changes and invites public comments by April 6, 2026.
Next: 2026-04237, Board of Scientific Counselors, National Center for Injury Prevention and Control; Notice of Charter Renewal
The CDC just renewed the Board of Scientific Counselors for the National Center for Injury Prevention and Control’s charter for two more years, keeping their important work going through January 13, 2028. This means the board will keep advising on injury prevention strategies that affect public health, with no new costs announced. The renewal ensures the board stays active and ready to tackle injury-related challenges ahead.